NDA 17594, held by Westwood Squibb. Chloroxine.
As of Nov 13, 2026, NDA 17594 (Capitrol), held by Westwood Squibb, was first approved by FDA on Oct 19, 1976, with 15 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 19, 1976 | Original applicationNew molecular entity · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Capitrol2% · shampoo;topical | Chloroxine | Discontinued |
| Feb 8, 1989 | Supplement 18Manufacturing · Standard review | Approved | None posted |
| Aug 8, 1988 | Supplement 15Manufacturing · Standard review | Approved | None posted |
| Sep 15, 1987 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| May 13, 1986 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Feb 13, 1986 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Nov 13, 1984 | Supplement 8Labeling · Standard review | Approved | None posted |
| Oct 14, 1982 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Mar 24, 1982 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Jun 11, 1981 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Jan 30, 1981 | Supplement 7Manufacturing · Standard review | Approved | None posted |
| Jan 30, 1981 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Aug 14, 1980 | Supplement 5Manufacturing · Standard review | Approved | None posted |
| May 1, 1980 | Supplement 4Manufacturing · Standard review | Approved | None posted |
| Apr 3, 1979 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Apr 27, 1978 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 19, 1976 | Original applicationNew molecular entity · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters